Takeda (China) International Trading Co., LtdShanghai, China (People's Republic)
Disclosure information not submitted.
MON-202 - Patient Characteristics, Treatment Patterns, and Resource Usage in Children Diagnosed with Central Precocious Puberty in China: A Real-World Retrospective Study
Monday, June 15, 20269:00 AM - 2:00 PM CT
MON-246 - Efficacy and Safety of 3-Month Leuprorelin Acetate Microspheres in Chinese Children with Central Precocious Puberty: A Prospective Multicenter Study
ORF47-02 - Efficacy and Safety of 3-Month Leuprorelin Acetate Microspheres in Chinese Children with Central Precocious Puberty: A Prospective Multicenter Study
Monday, June 15, 20261:50 PM - 1:55 PM CT
.jpg)
.jpg)